Clinical trial
A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate
To determine safety and tolerability and efficacy of chronic oral administration of PTK787/ZK222584 in the treatment of imatinib-resistent GISTs
| Category | Value |
|---|---|
| Study start date | 2007-03-15 |